Studieoverzicht
|
BOOG nr.: |
Status: ( Submitted (METC) )
|
Indication: ( View all )
|
Subindication: |
Menopausal status: |
| 2022-05 EMBER-4 | Submitted (METC) | Adjuvant | HER2- HR+ | Both pre- and postmenopausal |